Entero Healthcare Solutions Ltd. (ENTERO) - Total Liabilities

Latest as of March 2026: Rs18.48 Billion INR ≈ $199.82 Million USD

Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has total liabilities worth Rs18.48 Billion INR (≈ $199.82 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Entero Healthcare Solutions Ltd. to track the company's year-over-year net asset growth rate.

Entero Healthcare Solutions Ltd. - Total Liabilities Trend (2019–2025)

This chart illustrates how Entero Healthcare Solutions Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See ENTERO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Entero Healthcare Solutions Ltd. Competitors by Total Liabilities

The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their total liabilities.

Company Country Total Liabilities
TOMTOM N.V.ADRS 1/2 EO-20
F:OEMB
Germany €565.10 Million
Jiangsu Canlon Building Materials Co Ltd
SHE:300715
China CN¥3.76 Billion
Kvika banki hf
IC:KVIKA
Iceland Ikr295.12 Billion
ZheJiang RIFA Digital Precision Machinery Co Ltd
SHE:002520
China CN¥1.54 Billion
Anhui Korrun Co Ltd
SHE:300577
China CN¥3.51 Billion
Hubei Century Network Technology Co Ltd
SHE:300494
China CN¥136.87 Million
Chongqing QinAn M&E PLC
SHG:603758
China CN¥1.26 Billion
Mattr Corp
TO:MATR
Canada CA$849.48 Million

Liability Composition Analysis (2019–2025)

This chart breaks down Entero Healthcare Solutions Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Entero Healthcare Solutions Ltd. worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.58 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.51 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Entero Healthcare Solutions Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Entero Healthcare Solutions Ltd. (2019–2025)

The table below shows the annual total liabilities of Entero Healthcare Solutions Ltd. from 2019 to 2025.

Year Total Liabilities Change
2025-09-30 Rs18.48 Billion
≈ $199.82 Million
+98.22%
2024-09-30 Rs9.32 Billion
≈ $100.81 Million
+32.49%
2023-09-30 Rs7.04 Billion
≈ $76.09 Million
-9.37%
2022-09-30 Rs7.76 Billion
≈ $83.96 Million
+37.95%
2021-09-30 Rs5.63 Billion
≈ $60.86 Million
+62.31%
2020-09-30 Rs3.47 Billion
≈ $37.50 Million
+6.68%
2019-09-30 Rs3.25 Billion
≈ $35.15 Million
--

About Entero Healthcare Solutions Ltd.

NSE:ENTERO India Medical Distribution
Market Cap
$585.06 Million
Rs54.10 Billion INR
Market Cap Rank
#11174 Global
#565 in India
Share Price
Rs1243.00
Change (1 day)
+1.70%
52-Week Range
Rs949.20 - Rs1354.40
All Time High
Rs1549.55
About

Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more